India Blister Packaging Market Size, Share, Opportunities And Trends By Type (Compartment, Slide, Wallet), By Material (PVC, PVDC, PP, Others), By Technology (Cold-Form, Thermoformed) And By End-User (Consumer Goods, Food, Pharmaceutical, Others) - Forecasts From 2025 To 2030

India Blister Packaging Market Size:

The Indian Blister Packaging Market is estimated to attain a market size of USD 1,258.573 million by 2030, growing at a 7.39% CAGR from a valuation of USD 881.03 million in 2025.  

India Blister Packaging Market Introduction:

The blister packaging market in India is growing rapidly. This growth is mainly driven by the expansion of the pharmaceutical industry, rising healthcare awareness, and the need for safe, tamper-evident, and unit-dose packaging solutions. As India becomes a key player in producing and exporting generic medicine, blister packs have become crucial for meeting international regulations, ensuring drug stability, and improving patient safety. Government initiatives like Ayushman Bharat and greater access to healthcare in Tier II and Tier III cities are increasing the need for scalable, cost-effective, and compliant packaging formats, with blister packaging becoming the preferred choice.

The healthy growth of the country’s blister packaging market is attributable to the rise and growth in the pharmaceutical sector, food processing industry, consumer goods industry, and others, during the forecast period. According to the Indian Government, India is the largest producer and provider of generic drugs globally. India’s generic medicine sector contributes to approximately 40% of the United States' generic drugs demand. Indian companies received over 304 Abbreviated Novel Drug application approvals from the USFDA in 2017.

Moreover, the growth in the fast consumer goods industry in India is expected to have a positive effect on the blister packaging market. According to the India Brand Equity Foundation, the packaged food market in the country is expected to reach US$70 billion by 2025. The industry or the sector had received US$16.28 billion between April 2000 and March 2020. Major companies have been investing a significant sum of capital into the country’s blister packaging market in recent years. 

In line with this, the Indian healthcare market, which was valued at US$110 billion in FY16, is now projected to reach US$638 billion by FY25. In the Union Budget 2025–2026, the government has set aside Rs. 99,858 crore (US$11.50 billion) for the country's healthcare system's advancement, upkeep, and improvement. Compared to the FY25 allocation of Rs. 90,958 crore (US$10.47 billion), this represents a 9.78% increase. The need for safe, affordable, and impenetrable packaging solutions will increase as pharmaceutical production increases to satisfy growing demand from expanded public healthcare programs, including the distribution of generic medications under programs like Jan Aushadhi. Drug supply chains in the public and private sectors are expected to adopt blister packaging more frequently due to its benefits in dosage accuracy, shelf life, and compliance.

Another important factor is the focus on patient adherence, hygiene, and easy-to-use packaging. Blister packaging offers precise dosing, reduces waste, and adds convenience, especially for children and the elderly. The market is also influenced by a shift toward high-barrier materials, child-resistant formats, and recyclable films. There is a growing demand for sustainable and innovative packaging. These trends encourage Indian packaging companies to adopt automation, improve material quality, and meet changing pharma-grade standards for both domestic use and exports.

India’s blister packaging landscape includes both local leaders and international companies. Firms like Uflex Limited and Bilcare Limited lead the market, offering high-barrier foils, cold-form packs, and advanced polymer films with integrated manufacturing. Huhtamaki PPL delivers pharmaceutical laminates and foil-based packaging through extensive operations in India. Meanwhile, global companies like Amcor, Constantia Flexibles, and WestRock have set up or expanded their operations in India to meet rising regional demand.

Gualapack Pharma is further setting new industry standards with its cutting-edge digital printing solutions for aluminum and PVC blister foil production. This innovative technology offers unparalleled advantages, ensuring quality, flexibility, and speed to meet the dynamic demands of the pharmaceutical packaging sector.

Although leading players are becoming more self-sufficient through backwards integration, many still source critical materials like PVDC films, aluminum foils, and barrier laminates from China. However, with government support for domestic manufacturing through the Atmanirbhar Bharat and PLI schemes, India is gradually decreasing its dependence on imports and strengthening its position as a global hub for blister packaging.

India Blister Packaging Market Drivers:

• Growth in the pharmaceutical industry

The market is expected to surge in the coming years owing to the continuous growth in the pharmaceutical industry across India. According to the India Brand Equity Foundation, the country’s pharmaceutical sector supplies over 50% of the worldwide generic drugs. Currently, over 80% of the antiviral medicines and drugs, by the Indian form, have been used to combat AIDS. There are over 10,000 pharmaceutical companies in the country, which makes the industry highly fragmented and competitive. There are over 2,000 World Health Organization GMP-approved plants in the country. Blister packaging is one of the most common packaging sources used in the packaging of drugs and medicines in the country.

The major reason is due to its lightweight and lower volume occupancy rate, which makes it an attractive proposition for the pharmaceutical industry. The country’s per capita packaging consumption rate had been less than US$15, with an average global rate of US$100. Currently, there are more than 600 small and medium packaging machinery manufacturers in the country, and the numbers are expected to surge in the coming years because of the major government push for a self-reliant India and enhancing domestic manufacturing and packaging capabilities. Major companies have been launching medicines, which have been packaged in blister packs. In August 2020, Camber Pharmaceuticals announced the launch of Mesalamine suppositories, which had been used to treat mild ulcerative colitis. The product had been available in Camber 1000 mg, 30 ct blister pack.

India’s pharmaceutical industry is shifting from being a volume-based producer of generic drugs to focusing on value and innovation. As investment in research, biologics, and specialty formulations increases, packaging requirements have become more complex. This makes blister packaging a key part of drug delivery systems. Blister packs provide benefits like product isolation, precise dosing, and better shelf stability. These features are important for keeping drugs effective in India’s diverse climate. As pharmaceutical companies shift to high-value, precision medicines, the demand for reliable, high-barrier, and compliant packaging is growing quickly.

The Indian pharmaceutical market is projected to grow to a size of US$65 billion by 2024, approximately US$130 billion by 2030, and US$450 billion by 2047. The Indian pharmaceutical industry is valued at around US$50 billion, with over US$25 billion of that value derived from exports, according to government data. India accounts for around 20% of the world's generic drug exports.

The expansion of Indian pharmaceutical companies in global markets has raised the need for packaging that meets regulatory requirements. Exports are steadily increasing to regions with strict regulations like North America, Europe, and Southeast Asia. Blister packaging is often chosen for its ability to meet tough standards for labeling, serialization, and preventing counterfeiting. Additionally, the rise of contract manufacturing and third-party production has led to more use of standardized blister packaging formats, which provide scalability, efficiency, and better product tracking throughout the supply chain.

Domestically, India’s pharmaceutical market is experiencing strong demand from both the public and private healthcare sectors. The rise of low-cost medicine outlets under the Jan Aushadhi scheme and improved access to over-the-counter and chronic care medicines have made blister packs the preferred choice for widespread distribution. They help reduce contamination risks and offer a cost-effective, user-friendly solution for consumers from all income levels. This strong trend in consumption, along with increasing government incentives and investments in manufacturing, positions blister packaging as a rapidly growing segment tied to the future of Indian pharmaceuticals.

• Increasing usage of PVC

The market growth is mainly driven by the pharmaceutical industry for primary blister packaging materials in India. PVC is the third most used synthetic plastic polymer because of its characteristic, that it does not hamper the packed item in it. Indian plastic industry has been producing PVC from raw materials without relying on imports and exporting a wide range of PVC and other plastic-based products. The main hindrance to the use of PVC in blister packaging is that it leaves the carbon print which also leads to government regulations and hence, restraint the growth of PVC blister packaging in India. This creates an opportunity for technological advancements in the packaging industry. In 2019, Uflex’s alu-alu packaging was awarded at the 4th Annual India Packaging Awards for sustainable innovations in the packaging industry (Source: Print Week). India has a huge potential in the packaging industry as technological advancement is not going at the same pace as the demand and growth expected.

The pandemic has further boosted the demand of the pharmaceutical industry as people have become more health-conscious, which has led to an increase in the demand for over-the-counter drugs, which further boosts the demand for the PVC blister packaging market in India. However, environmental sustainability and technological advancement are what create both a hindrance and an opportunity for the firms to enter and grow in the Indian market.

India Blister Packaging Market Segmentation Analysis:

• The pharmaceutical sector is gaining significant market share

By end-user, the Indian blister packaging market is segmented into consumer goods, food, and pharmaceuticals. Indian pharmaceutical industry is the third largest by volume globally, and over the years, it has witnessed a constant growth fuelled by the growing demand for qualitative medicine and investment in new drug manufacturing. Likewise, the country accounts for nearly 20% of global generic drugs supply and produces nearly 60,000 varied generic brands across 60 therapeutic areas. The ability of a nation to offer low-priced and high-quality medicines, followed by growing infectious disease prevalence, has bolstered the overall turnover. According to the Department of Pharmaceuticals' “Annual Report 2023-2024”, India’s turnover stood at Rs. 4,17,345 crores, marking 10% growth over 2022’s turnover. 

Furthermore, to sustain market growth and ensure better consumer awareness, the Government of India has implemented strict rules regarding rules and regulations of packaging and labelling. A good number of companies in India use Aluminum blister foils as they are cost-effective and comply with rules and regulations. Further, labelling becomes easier for companies.

Moreover, packaging companies in the industry are ensuring product safety along with sustainability to comply with the government safety standards. For instance, Huhtamaki’s “Push Tab” blister lid is the company’s latest innovation made from mono-material PET, which further improves its recyclability. Likewise, India-based major companies such as Uflex Limited have been investing in new developments. For instance, the company’s PET base Alu-Alu Laminate for packaging for pharmaceutical products is cost-effective, convenient, and environment-friendly.

India Blister Packaging Market Key Developments:

• Formpack® Dessiflex® Blister System: It is AMFoil-based for healthcare use. It integrates desiccant particles within a PVC-free sealant layer, offering superior moisture protection and fracture-free forming. It enhances shelf life, accelerates product launches, ensures patient safety with anti-counterfeiting features, and reduces packaging and production costs.   
• AmSky™ Blister System: AmSky™ is Amcor’s vinyl- and aluminum-free PE-based blister system designed for recyclability in rigid and flexible streams, offering a lower carbon footprint. It has applications for nutraceuticals, oral, and pulmonary. It is used for all blisters, Printable using UV Flexo Multiple Gauges to offer a tailored moisture barrier.
• Acquisition (2023): Amcor acquired Phoenix Flexibles in India, aiming to expand Amcor's capacity. 

 Market Segmentation:

• By Type
  • Compartment
  • Slide
  • Wallet
• By Material
  • PVC
  • PVDC
  • PP
  • Others
• By Technology
  • Cold-Form
  • Thermoformed
• By End-User
  • Consumer Goods
  • Food
  • Pharmaceutical